Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
There have been significant advances allowing for the integration of mucopolysaccharidosis I into newborn screening programs. Initial experiences using a single-tier approach for this disorder have highlighted shortcomings that require immediate remediation. The recent evaluation of a second-tier bi...
Saved in:
Main Authors: | Lorne A. Clarke (Author), Patricia Dickson (Author), N. Matthew Ellinwood (Author), Terri L. Klein (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
by: M. Christine Dorley, et al.
Published: (2023) -
Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
by: Barbara K. Burton, et al.
Published: (2020) -
Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
by: Zackary M. Herbst, et al.
Published: (2020) -
Enzymatic testing for mucopolysaccharidosis type I in Kuwaiti newborns: a preliminary study toward newborn screening
by: Hind Alsharhan, et al.
Published: (2024) -
Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I
by: Dawn S. Peck, et al.
Published: (2020)